These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 33859125)
1. Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence. Schulze-Schiappacasse C; Durán J; Bravo-Jeria R; Verdugo-Paiva F; Morel M; Rada G J Clin Rheumatol; 2022 Mar; 28(2):e563-e567. PubMed ID: 33859125 [TBL] [Abstract][Full Text] [Related]
2. Neuromodulators for pain management in rheumatoid arthritis. Richards BL; Whittle SL; Buchbinder R Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008921. PubMed ID: 22258992 [TBL] [Abstract][Full Text] [Related]
3. Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials. Fitzcharles MA; Baerwald C; Ablin J; Häuser W Schmerz; 2016 Feb; 30(1):47-61. PubMed ID: 26767993 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoids for the treatment of cannabis abuse disorder. Rodríguez A; Zavala C Medwave; 2018 Oct; 18(6):e7287. PubMed ID: 30339139 [TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
7. Are cannabinoids an effective treatment for chronic non-cancer pain? Allende-Salazar RF; Rada G Medwave; 2017 Jun; 17(Suppl2):e6972. PubMed ID: 28622286 [TBL] [Abstract][Full Text] [Related]
8. Cannabis-based medicines for chronic neuropathic pain in adults. Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoids for Treatment of MS Symptoms: State of the Evidence. Rice J; Cameron M Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025 [TBL] [Abstract][Full Text] [Related]
10. Cannabis-based medicinal products in arthritis, a painful conundrum. Berg MVD; John M; Black M; Semprini A; Oldfield K; Glass M; Braithwaite I N Z Med J; 2020 May; 133(1515):35-45. PubMed ID: 32438375 [TBL] [Abstract][Full Text] [Related]
11. Are cannabinoids effective for treatment of pain in patients with active cancer? Lobos Urbina D; Peña Durán J Medwave; 2016 Sep; 16 Suppl 3():e6539. PubMed ID: 27635982 [TBL] [Abstract][Full Text] [Related]
12. Do cannabinoids constitute a therapeutic alternative for anorexia nervosa? Contreras T; Bravo-Soto GA; Rada G Medwave; 2017 Dec; 17(9):e7095. PubMed ID: 29194432 [TBL] [Abstract][Full Text] [Related]
13. Cannabis-Based Products for Chronic Pain : A Systematic Review. McDonagh MS; Morasco BJ; Wagner J; Ahmed AY; Fu R; Kansagara D; Chou R Ann Intern Med; 2022 Aug; 175(8):1143-1153. PubMed ID: 35667066 [TBL] [Abstract][Full Text] [Related]
14. Herbal medicinal products or preparations for neuropathic pain. Boyd A; Bleakley C; Hurley DA; Gill C; Hannon-Fletcher M; Bell P; McDonough S Cochrane Database Syst Rev; 2019 Apr; 4(4):CD010528. PubMed ID: 30938843 [TBL] [Abstract][Full Text] [Related]
15. Are cannabinoids effective for Parkinsons disease? Bravo-Soto GA; Juri C Medwave; 2017 Jun; 17(Suppl2):e6974. PubMed ID: 28622283 [TBL] [Abstract][Full Text] [Related]
16. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy]. Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763 [TBL] [Abstract][Full Text] [Related]
17. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Fisher E; Moore RA; Fogarty AE; Finn DP; Finnerup NB; Gilron I; Haroutounian S; Krane E; Rice ASC; Rowbotham M; Wallace M; Eccleston C Pain; 2021 Jul; 162(Suppl 1):S45-S66. PubMed ID: 32804836 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: Overview of systematic reviews. Riera R; Pacheco RL; Bagattini ÂM; Martimbianco ALC Phytother Res; 2022 Jan; 36(1):5-21. PubMed ID: 34841610 [TBL] [Abstract][Full Text] [Related]
20. Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity. Verhoef LM; van den Bemt BJ; van der Maas A; Vriezekolk JE; Hulscher ME; van den Hoogen FH; Jacobs WC; van Herwaarden N; den Broeder AA Cochrane Database Syst Rev; 2019 May; 5(5):CD010455. PubMed ID: 31125448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]